About Monomer Bio
Monomer Bio is a Healthcare company based in Pacifica (United States) founded in 2021 by Jimmy Sastra and Mark Zhang. Monomer Bio has raised $5.6 million across 1 funding round from investors including Talis Capital. Its chief executive, as recorded, is Jimmy Sastra. Monomer Bio offers products and services including Cell Culture Telemetry and Automation Tools. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Laboratory Management. Its legal entity is SB HOMES LLC. Its competitors include Waters Corporation, Emerald Therapeutics and Quartzy; 2 of its 3 listed competitors have raised funding.
Company details
Provider of lab automation solutions for biology research. It combines lab automation execution software with data capture, management, and AI-guided analysis that simplifies the operation of cell culture workflows.
- Headquarters Pacifica, United States
- Founders Jimmy Sastra, Mark Zhang
- SectorsHealthcare
- Email••••••••
- Website monomerbio.com
- Social LinkedIn
- Legal Name Sb Homes Llc
- Total Equity Funding$5.6M (USD)
in 1 rounds
- Latest Funding Round$5.6M (USD), Seed
Feb 2024
- Investors
Products & Services of Monomer Bio
Monomer Bio offers a comprehensive portfolio of products and services, including Cell Culture Telemetry and Automation Tools.
Tracks cell growth and environmental data for real-time analysis.
Automates protocols to enhance cell culture workflows and efficiency.
Funding Insights of Monomer Bio
Monomer Bio has successfully raised a total of $5.6M through 1 strategic funding round. The most recent funding activity was a Seed round of $5.6 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.6M
- Total Rounds 1
- Last Round Seed — $5.6M
- First Round $5.6M
(Feb 2024)
- Investors Count 1
All 1 funding rounds of Monomer Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $5.6M | Seed | – | Talis Capital | – |
1 investors in total: 1 institutional.
Investors in Monomer Bio
Monomer Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Talis Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund investing in tech startups | taliscapital.com | London, United Kingdom |
Investor details for Monomer Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Monomer Bio
4 people are tracked at Monomer Bio (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Jimmy Sastra | Co-Founder & CEO | Leadership |
Mark Zhang | Co-Founder | Leadership |
Carter Allen | Founding Application Specialist | Team |
Yang C. | Site Lead | Team |
Complete people profiles for Monomer Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Monomer Bio
2 dated milestones of Monomer Bio across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Monomer Bio is founded.
- Funding First funding round of $5.6M.
Competitors of Monomer Bio
Monomer Bio has 3 listed competitors in our database, 2 of them funded. They include Waters Corporation, Emerald Therapeutics and Quartzy.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| waters.com | 1958 | Milford, United States | 9,341 | Provider of laboratory management system for researchers and clinicians | ||
| emeraldcloudlab.com | 2010 | San Francisco, United States | $39.5M | 77 | Cloud-based remote lab automation software is offered for life sciences. | |
| quartzy.com | 2009 | Palo Alto, United States | $33.87M | 97 | Lab management platform for life sciences is offered by Quartzy. |
Detailed competitors of Monomer Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Monomer Bio
The website of Monomer Bio (monomerbio.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 23% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Monomer Bio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Monomer Bio
Complete news archive for Monomer Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monomer Bio
Monomer Bio was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Monomer Bio is headquartered in Pacifica, United States. It is registered at Pacifica, California, United States.
Jimmy Sastra is the CEO of Monomer Bio, as recorded in our data. They have also founded this company.
Monomer Bio is a funded company, having raised a total of $5.6M across 1 funding round to date. The company's 1st funding round was a Seed of $5.6M, raised on Feb 2024.
Provider of lab automation solutions for biology research. It combines lab automation execution software with data capture, management, and AI-guided analysis that simplifies the operation of cell culture workflows.
Monomer Bio's top competitors include Waters Corporation, Quartzy and Emerald Therapeutics.
Monomer Bio offers Cell Culture Telemetry and Automation Tools.
Monomer Bio has 1 investor. Key investors include Talis Capital.
Monomer Bio operates through Sb Homes Llc.